Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C15M | ISIN: CA67577H1047 | Ticker-Symbol: 2QB0
Frankfurt
27.06.25 | 08:02
0,192 Euro
+2,13 % +0,004
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
OCUMETICS TECHNOLOGY CORP Chart 1 Jahr
5-Tage-Chart
OCUMETICS TECHNOLOGY CORP 5-Tage-Chart

Aktuelle News zur OCUMETICS TECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrOcumetics Technology Corp: Ocumetics completes virtual site visit in Mexico City2
DoOcumetics Technology Corp.: Ocumetics Completes Virtual Site Initiation for First-In-Human Clinical Study of Accommodating Intraocular Lens1
MiOcumetics Technology Corp: Ocumetics prepares for Ocumetics FIH clinical studies1
DiOcumetics Technology Corp.: First-In-Human Study of Accommodating Intraocular Lens Set to Begin June 26, 20251
OCUMETICS TECHNOLOGY Aktie jetzt für 0€ handeln
04.06.Ocumetics Technology Corp: Ocumetics Technology arranges $2.1-million financing-
04.06.Ocumetics Technology Corp.: Ocumetics Announces Private Placement1
04.06.Ocumetics Technology Corp: Ocumetics sets June 26 as start date for FIH study1
03.06.Northern Dynasty, Ocumetics, Star Copper at 52-Week Highs on News43
03.06.Ocumetics Technology Corp.: Ocumetics Targets June 26, 2025 for Commencement of its First in Human Study1
03.06.Ocumetics Technology Corp: Ocumetics to hold intraocular lens FIH clinical study1
02.06.Ocumetics Technology Corp.: Ocumetics Announces Mexico City as Site for its First in Human Study1
23.05.Ocumetics Technology Corp: Ocumetics submits FIH clinical study protocol to IRB2
22.05.Ocumetics Technology Corp.: Ocumetics Clinical Study Protocol Submission and Site Initiation on Schedule for Summer 20251
15.05.Ocumetics Technology Corp: Ocumetics makes lens for human clinical study in summer1
14.05.Ocumetics Technology Corp.: Ocumetics Completes Manufacturing of Lenses to be used in First-in-Human Study3
13.05.Ocumetics Technology Corp: Ocumetics begins lens design freeze for FIH study3
12.05.Ocumetics Technology Corp.: Ocumetics Announces Lens Design Freeze for First-in-Human Study1
08.05.Ocumetics' corrective lens meets key milestone before human trials1
08.05.Ocumetics Technology Corp.: Ocumetics Achieves Key Milestone: Laboratory Testing Confirms Accommodative Power Target was Successfully Achieved in Preparation for First-in-Human Trials2
02.05.Ocumetics Technology Corp: Ocumetics director Marks resigns3
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1